New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2013
19:04 EDTTXI, VOXX, STJ, RT, QUIK, PSMTOn The Fly: After Hours Movers
UP AFTER EARNINGS: VOXX International (VOXX), up 16%... PriceSmart (PSMT), up 5.8%... DOWN AFTER EARNINGS/GUIDANCE: Ruby Tuesday (RT), down 8.6%... Texas Industries (TXI), down 8.6%... QuickLogic (QUIK), down 10.8% after lowering its Q4 revenue outlook... St. Jude Medical (STJ), down 3.4% after providing preliminary Q4 guidance.
News For VOXX;PSMT;RT;TXI;QUIK;STJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2015
10:00 EDTSTJOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:05 EDTSTJSt. Jude Medical price target raised to $85 from $77 at Leerink
Subscribe for More Information
06:40 EDTSTJSt. Jude Medical upgraded to Outperform from Neutral at Credit Suisse
Subscribe for More Information
April 22, 2015
08:49 EDTSTJSt. Jude Medical sees FY16 a 'strong year' for neuromodulation segment
Subscribe for More Information
08:30 EDTSTJSt. Jude Medical sees FY15 CRM constant currency sales down 2% to flat with FY14
Sees FY15 AF product sales growth of 12%-14%. Backs cardiovascular product sales growth view of 6%-8%. Sees neuromodulation products sales growth 13%-15%. Sees acquisition of spinal modulation reducing FY15 EPS by about 5c and accretive to FY16 EPS. Guidance provided during Q1 earnings conference call.
07:18 EDTSTJSt. Jude Medical sees Q2 adjusted EPS 99c-$1.01, consensus 99c
For the second quarter, St. Jude Medical expects revenue to grow in the range of 4%-5% on a constant currency basis compared to the second quarter of 2014 with currency negatively impacting second quarter revenue by approximately $125M-$135M. Revenue consensus is $1.4B.
07:18 EDTSTJSt. Jude Medical sees FY15 adjusted EPS $3.92-$3.97, consensus $3.95
Subscribe for More Information
07:16 EDTSTJSt. Jude Medical reports Q1 total CRM sales $643M, down 6% y/y
Subscribe for More Information
07:16 EDTSTJSt. Jude Medical reports Q1 adjusted EPS 93c, consensus 91c
Reports Q1 revenue $1.35B, consensus $1.32B.
April 21, 2015
15:28 EDTSTJNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Coca-Cola (KO), consensus 42c... Boeing (BA), consensus $1.81... McDonald's (MCD), consensus $1.06... EMC (EMC), consensus 36c... Abbott Laboratories (ABT), consensus 42c... Thermo Fisher Scientific (TMO), consensus $1.61... Bank of New York Mellon (BK), consensus 59c... TE Connectivity (TEL), consensus $1.01... T. Rowe Price Group (TROW), consensus $1.14... St. Jude Medical (STJ), consensus 91c... Amphenol (APH), consensus 56c... Nielsen (NLSN), consensus 47c... Citizens Financial Group (CFG), consensus 34c... Autoliv (ALV), consensus $1.31... D.R. Horton (DHI), consensus 38c... Westinghouse Air Brake Technologies (WAB), consensus 95c... Huntington Bancshares (HBAN), consensus 19c... SEI Investments (SEIC), consensus 49c... AutoNation (AN), consensus 89c... Gentex (GNTX), consensus 25c... Ryder System (R), consensus $1.00... Owens Corning (OC), consensus 13c... NuStar Energy (NS), consensus 58c... Six Flags (SIX), consensus (67c)... Tupperware Brands (TUP), consensus 98c... MarketAxess Holdings (MKTX), consensus 64c... Lithia Motors (LAD), consensus $1.22... Knight Transportation (KNX), consensus 31c... Evercore Partners (EVR), consensus 58c... Potlatch (PCH), consensus 19c... Natus Medical (BABY), consensus 29c... AZZ (AZZ), consensus 59c... United Community Banks (UCBI), consensus 29c... Sonus Networks (SONS), consensus (31c)... Angie's List (ANGI), consensus 0c... Pacific Premier Bancorp (PPBI), consensus 27c.
15:05 EDTSTJSt. Jude Medical technical comments ahead of earnings
Subscribe for More Information
April 20, 2015
09:03 EDTSTJSt. Jude Medical announces intent to acquire Spinal Modulation
Subscribe for More Information
April 13, 2015
10:00 EDTSTJOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:06 EDTPSMTPriceSmart underlying trends better than headline results, says Roth Capital
After PriceSmart reported lower than expected EPS, Roth Capital says that the results were hurt by certain one-time items and pressures that may soon abate. The firm believes that the company's fundamentals are nearing a positive turning point, while the shares look poised to increase significantly if currency pressures subside. Roth keeps a $95 price target and Buy rating on the shares.
06:33 EDTSTJSt. Jude Medical upgraded to Neutral from Underperform at Credit Suisse
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use